Companies

Anixa Biosciences Inc (ANIX) SEC filings

CIK 0000715446 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 10/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)210000210000512000
Net income (USD)-10.9 M-9.8 M-13.6 M
Diluted EPS (USD/shares)-0.34-0.320.45

Latest filings

FiledFormDescriptionPeriod
2026-09-30442026-09-30
2026-09-28442026-09-24
2026-09-28442026-09-24
2026-09-25442026-09-23
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-11442026-09-10
2026-09-0910-Q10-Q2026-07-31
2026-08-03442026-07-31
2026-07-29442026-07-27
2026-07-28442026-07-27
2026-07-27442026-07-27
2026-07-27442026-07-24
2026-07-21442026-07-20
2026-07-20442026-07-20
2026-07-16442026-07-15
2026-07-13442026-07-10
2026-06-17442026-06-16
2026-06-16442026-06-12
2026-06-1010-Q10-Q2026-04-30
2026-03-118-K8-K items 5.07,7.01,9.012026-03-10
2026-03-0910-Q10-Q2026-01-31
2026-02-098-K8-K items 7.01,9.012026-02-09
2026-01-29442026-01-28
2026-01-28DEF 14ADEF 14A2026-01-28

Forms on file (last 1,000): 4 433, 8-K 114, 10-Q 95, DEF 14A 31, 10-K 27, CORRESP 25, UPLOAD 25, S-8 22. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ANIX (0.002 USD), /gw/filings/filings?ticker=ANIX&form=8-K, /gw/filings/facts?ticker=ANIX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange